This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Mendus AB (publ)
Q22026
8/20/2026
Dr. Erik Manthing
CEO
Is there anything else we still need to discuss, Robert, with respect to clues, for example, because I will explicitly invite Lothar to present her slides. I think that's your cue to switch cameras. We have at the end a big fat Q&A on the slide, which opens the Q&A. Do you want me to indicate that we're happy to take any questions? Yes, please. That would be great. And then you take over with instructions, right?
Robert
Conference Moderator
Yeah. So my introduction will sound like this. So I'll just bring it up. Welcome to Mendo's Q2 2026 report presentation. We will begin with a presentation from the company speakers, CEO Dr. Erik Manthing and CFO Lotta Färm. Following the presentation, we will open up for questions. To ask a question, press star 5 on your telephone keypad to enter the queue. When it's your turn to speak, press star 6 to unmute. I will now hand over to CEO Dr. Erik Manthing. Please go ahead.
Dr. Erik Manthing
CEO
That's okay. And then, Robert, with respect to the actual questions being asked, I assume you select which questions will be asked or by whom. Do you know the names of the analysts that follow us?
You're reading a preview of the IMMU.ST Q2 2026 earnings call.
Free account.
Disclaimer